Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- Check7 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the study details page. This appears to be a metadata or maintenance update rather than a change to the study content itself.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a new revision of the page documentation. This reflects a minor update to the study record’s documentation rather than a substantive change to the study itself.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision: v3.6.2 is now shown on the page, replacing the previous Revision: v3.6.0. This reflects a small update to the page's revision metadata rather than a change to study information.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now states that recruitment has ended and no longer accepts participants. It also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting, along with a new revision tag (v3.6.0).SummaryDifference0.2%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page template or rendering. It does not alter the study data or visible information.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's revision tag changed from v3.5.3 to v3.5.4, replacing the old tag with a newer version indicator. This reflects an update to the page metadata rather than study details.SummaryDifference0.0%

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.